Paper41219992
Impact of seasonal malaria chemoprevention: a plausibility evaluation of routine data from health facilities in three implementing states in Nigeria.
Ikechukwu EC and 13 others. Malar J, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Impact of seasonal malaria chemoprevention: a plausibility evaluation of routine data from health facilities in three implementing states in Nigeria. Papers, record 41219992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41219992
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of seasonal malaria chemoprevention: a plausibility evaluation of routine data from health facilities in three implementing states in Nigeria.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chemoprevention | Major topic |
| Malaria | Major topic |
| Antimalarials | Major topic |
| Health Facilities | Major topic |
| Humans | |
| Nigeria | |
| Child, Preschool | |
| Infant | |
| Seasons | |
| Incidence | |
| Female | |
| Male |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27875528 | Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial. | PLoS Med | 2016 | https://conductscience.org/library/papers/27875528 | PubMed |
| 2 | 37950227 | Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South Sudan. | Malar J | 2023 | https://conductscience.org/library/papers/37950227 | PubMed |
| 3 | 37153452 | Effectiveness of seasonal malaria chemoprevention administered in a mass campaign in the Kedougou region of Senegal in 2016: a case-control study. | Wellcome Open Res | 2022 | https://conductscience.org/library/papers/37153452 | PubMed |
| 4 | 10195658 | Evaluation designs for adequacy, plausibility and probability of public health programme performance and impact. | Int J Epidemiol | 1999 | https://conductscience.org/library/papers/10195658 | PubMed |
| 5 | 36587191 | Effectiveness of seasonal malaria chemoprevention in three regions of Togo: a population-based longitudinal study from 2013 to 2020. | Malar J | 2022 | https://conductscience.org/library/papers/36587191 | PubMed |
| 6 | 22673908 | Estimating the potential public health impact of seasonal malaria chemoprevention in African children. | Nat Commun | 2012 | https://conductscience.org/library/papers/22673908 | PubMed |
| 7 | 12893608 | Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. | Am J Public Health | 2003 | https://conductscience.org/library/papers/12893608 | PubMed |
| 8 | 33278936 | Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. | Lancet | 2020 | https://conductscience.org/library/papers/33278936 | PubMed |
| 9 | 38081050 | Systematic Review and Meta-Analysis of Seasonal Malaria Chemoprevention. | Am J Trop Med Hyg | 2024 | https://conductscience.org/library/papers/38081050 | PubMed |
| 10 | 37542257 | Attitudes and prevention towards malaria in the context of COVID-19 pandemic in urban community in Benin, West Africa. | Malar J | 2023 | https://conductscience.org/library/papers/37542257 | PubMed |
| 11 | 36046715 | Increasing challenges of malaria control in sub-Saharan Africa: Priorities for public health research and policymakers. | Ann Med Surg (Lond) | 2022 | https://conductscience.org/library/papers/36046715 | PubMed |
| 12 | 38778226 | Household-level effects of seasonal malaria chemoprevention in the Gambia. | Commun Med (Lond) | 2024 | https://conductscience.org/library/papers/38778226 | PubMed |
| 13 | 37449257 | Effectiveness of seasonal malaria chemoprevention in reducing under-five malaria morbidity and mortality in the Savannah Region, Ghana. | Ghana Med J | 2022 | https://conductscience.org/library/papers/37449257 | PubMed |
| 14 | 35135546 | Effect of three years' seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali. | Malar J | 2022 | https://conductscience.org/library/papers/35135546 | PubMed |
| 15 | 34662864 | Modeled Impact of Seasonal Malaria Chemoprevention on District-Level Suspected and Confirmed Malaria Cases in Chad Based on Routine Clinical Data (2013-2018). | Am J Trop Med Hyg | 2021 | https://conductscience.org/library/papers/34662864 | PubMed |
| 16 | 31833469 | A Robust Estimator of Malaria Incidence from Routine Health Facility Data. | Am J Trop Med Hyg | 2020 | https://conductscience.org/library/papers/31833469 | PubMed |
| 17 | 26797239 | The "Efficacy-Effectiveness Gap": Historical Background and Current Conceptualization. | Value Health | 2016 | https://conductscience.org/library/papers/26797239 | PubMed |
| 18 | 38267985 | A quasi-experimental study to estimate effectiveness of seasonal malaria chemoprevention in Aweil South County in Northern Bahr El Ghazal, South Sudan. | Malar J | 2024 | https://conductscience.org/library/papers/38267985 | PubMed |
| 19 | 28049466 | Cost benefit analysis of malaria rapid diagnostic test: the perspective of Nigerian community pharmacists. | Malar J | 2017 | https://conductscience.org/library/papers/28049466 | PubMed |
| 20 | 34495978 | Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in 5 countries. | PLoS Med | 2021 | https://conductscience.org/library/papers/34495978 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41219992
GET https://conductscience.org/api/papers/v1/41219992/references?page=2